RIO DE JANEIRO, BRAZIL -Russia has approved a single-dose version of the Sputnik V vaccine against Covid-19 after it demonstrated nearly 80% efficacy, according to the state fund that supported its development.
The vaccine demonstrated nearly 80% efficacy, according to the state fund that supported its development.
The 79.4% efficacy rate of the vaccine, called Sputnik Light, is based on an analysis of real-world data, not a standard clinical trial, and interim results from the late-stage study are expected later this month, according to a statement from the Russian Direct Investment Fund (RDIF). Initial and . . .
To read the full NEWS and much more, Subscribe to our Premium Membership Plan. Already Subscribed? Login Here